EU plans under-13 social media ban, England approves life-extending cancer drug in a week of global wins
From a breast cancer drug reversal in England to Chile eliminating rabies and Iceland reviewing whaling, a single week delivered a string of concrete policy and public health advances.
Acabashi / Wikimedia Commons
In the space of a week, the European Union moved to wall off social media from young children, England reversed a two-year refusal to fund a life-extending cancer drug, and the World Health Organization certified Chile free of dog-transmitted rabies — a run of advances across child safety, public health and environmental policy that advocates had spent years pushing for.
The EU's proposal, unveiled on Wednesday by European Commission President Ursula von der Leyen, would ban social media for children under 13 outright. Teenagers aged 13 to 15 would be limited to one hour a day on platforms, accessed only through 'mini accounts' set up via a parent or guardian's profile. Crucially, the EU plans to place enforcement responsibility on app stores rather than the platforms themselves — a structural shift that experts say makes the rules harder to circumvent.
Many perceive the power of big tech as overwhelming and impossible to roll back. I disagree; we do not have to accept addictive social media designs. We do not have to accept children being drawn into ever more extreme content. It is us who decide our rules, not tech companies.— Ursula von der Leyen, President of the European Commission
Teens will find it much harder to circumvent these bans. The EU will succeed where Australia has so far failed.— Patrick Grady, Head of European Tech, Information Technology and Innovation Foundation
Not all observers are enthusiastic. Critics have raised privacy concerns, warning that age verification at the app-store level would require all users — not just children — to submit personal information to access platforms.
The days of tech exceptionalism and their systematic exploitation of children for profit are numbered.— Leanda Barrington-Leach, Executive Director, 5Rights
In England, a two-year patient campaign produced a different kind of reversal. The National Institute for Health and Care Excellence (NICE) had declined in 2024 to approve Enhertu — a drug for patients with incurable HER2-low metastatic breast cancer — on cost grounds, even as Scotland and 26 EU nations made it available. This week NICE overturned that decision. Clinical data show the drug gives patients an average of seven extra months of life, with some living up to three years longer.
This decision brings a renewed sense of hope, not only for me but for thousands of other women living with incurable HER2-low metastatic cancer. Hope of more precious time with our loved ones, hope I may still be here to support my nine-year-old daughter into high school.— Kathryn Hulland, campaigner
Charity Breast Cancer Now welcomed the decision and called on Wales and Northern Ireland to follow England's lead.
On the disease-elimination front, the WHO this week certified Chile as the first South American country to have eliminated dog-transmitted rabies as a public health problem — the result of more than five decades of canine vaccination, surveillance and access to post-bite medication. The announcement followed last week's equivalent certification for Bhutan.
This is a historic achievement that demonstrates the impact of sustained investment in public health.— Dr Tedros Adhanom Ghebreyesus, Director General, WHO
A new $15.5 million fund also launched this week with the goal of accelerating the end of female genital mutilation (FGM). The Her Horizon Fund was seeded with $14 million from the Wallace Global Fund, a private foundation, and $1.5 million from an anonymous donor. The launch comes as donor funding to frontline health organisations working against FGM has declined sharply — even as an estimated 4.4 million girls remain at risk of being cut each year, leaving the world off-track to meet the UN's 2030 elimination goal.
We're at this critical inflection point. Most frontline organisations have been absolutely starved for resources. More direct funding would allow them to sustain and scale [up] their work.— Susan Gibbs, Her Horizon Fund
Iceland, one of only four jurisdictions — alongside Japan, Norway and the Faroe Islands — that still permit commercial whaling despite the 1986 global moratorium, announced this week that its government will conduct a review of whaling legislation next February, with a permanent ban a possible outcome. Nonprofit Humane World for Animals noted that some 80 adult fin whales have already been hunted in Icelandic waters this season.
This is a really significant milestone in efforts to consign to history Iceland's cruel and needless whale hunts. There is considerable political and public support for this bill to ban commercial whaling, and compelling ethical, veterinary, legal and conservation reasons to hope it succeeds.— Wendy Higgins, Director of Media, Humane World for Animals
Closer to home, Bristol's Green-led council voted on Monday to ban advertising for fossil fuels, flights, SUVs and — in a first for the UK — ultra-fast fashion on council-run hoardings. The city joins Amsterdam, Cardiff and Edinburgh in restricting polluting ads on public infrastructure.
We don't want Bristol to be a billboard for polluters while we're working hard to improve health, air quality and nature in the city.— Heather Mack, Deputy Leader, Bristol City Council
Several of this week's developments — the Enhertu approval, the EU social media proposals, the Iceland whaling review — are the result of sustained multi-year campaigns by patients, charities and advocacy groups, illustrating how long the gap can be between a policy goal being identified and it being acted upon.
Why it matters — Each of these developments — from the EU's social media rules to England's cancer drug U-turn — directly affects millions of people's daily lives and shows how sustained advocacy can shift entrenched policy positions.
⚠ Not yet confirmed
- A new wild cat species called the tilcayo was identified in Bolivia, described as the first new cat species in over a century
- A well-preserved 600-year-old elite tomb was unearthed in Peru and described as a major archaeological find
- Reading was linked to better health outcomes
- new wild cat species (tilcayo) in Bolivia and 600-year-old tomb in Peru
- A new wild cat species called the tilcayo was identified in Bolivia — the first new cat species in over a century
Reported by positive.news, goodnewsbears.news, goodgoodgood.co
- Tedros Adhanom GhebreyesusEthiopian and politician, Director-General of the World Health Organization